AHCC - ImmPower

ImmPower : Produced by American Biosciences of Blauvelt, NY  

A fermented extract produced from the mycelium of hybridized medicinal mushrooms grown in the extract of rice bran, AHCC been shown to significantly improve the immune system by increasing the production of the body’s “killer cells”, whose function is to destroy abnormal cells and invading organisms in the body.

Currently used in over 700 clinics throughout Asia, AHCC has gained wide acceptance due to the volume of research devoted to its applications. As the subject of over 100 research papers from the world’s leading research centers, AHCC has been studied at prestigious U.S. institutions such as the UC Davis Cancer Center, Columbia Presbyterian Medical Center, the Yale School of Medicine and the Harvard-affiliated Brigham and Women’s Hospital, among others.

The most important factor driving the acceptance of AHCC at cancer clinics has been its impact on reducing the side effects of chemotherapy. AHCC has been shown to help reverse the suppression of immunity (that results from cytotoxic chemotherapy treatments) by significantly raising patients’ white blood cell counts, as well as contribute to the prevention of chemically induced alopecia (hair loss), the reduction of nausea and vomiting and the protection of the bone marrow (by helping prevent myelo-supression and anemia, which contribute to the patient’s fatigue). Read full article here.

Research shows provides unsurpassed support for the immune system's front-line defenses:*

  • Maintaining peak Natural Killer cell function*
  • Supporting enhanced cytokine production*
  • Promoting optimal T-cell and macrophage activity*

"Animal studies suggest that AHCC has antioxidant effects and may protect against disorders induced by oxidative stress and also enhance resistance against bacterial and viral infections.

A study of healthy subjects aged 50 years and older suggests that AHCC improves T-cell immune responses via increased production of interferon-l and tumor necrosis factor-alpha for up to 30 days after treatment. In healthy humans, AHCC increased dendritic cell number and function."

Herb-Drug Interactions:  AHCC can induce CYP450 2D6. This may decrease the activity of other drugs, like doxorubicin or ondansetron, which are substrates of this enzyme.  Read full article here.